Observational Study of Ketamine Infusions for the Treatment of Chronic Pain

Theresa Lii

Status

Invitation-only

Conditions

Chronic Pain

Treatments

Drug: Ketamine

Study type

Observational

Funder types

Other

Identifiers

NCT05477004

62561

Details and patient eligibility

About

This observational study will collect prospectively specified data on patient characteristics and clinically relevant outcomes in patients who receive a ketamine infusion at Stanford Pain Management Center for the treatment of chronic pain, with the goal of identifying treatment responders and relationships between patient characteristics and treatment response.

Full description

Ketamine is a type of anesthetic drug which has been used off-label to treat chronic pain. The effectiveness of intravenous ketamine and its duration of effect are not well-understood. There is high variability in response to ketamine, and it remains unclear which patient characteristics are associated with favorable outcomes. This observational study will collect a wide range of patient-reported outcomes via digital surveys: once at baseline before treatment, and up to 7 follow-up surveys for up to 12 months following a single ketamine infusion. Survey data will be supplemented by clinical data obtained from electronic medical records.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Has been seen at Stanford's Pain Management Center for a doctor's visit at least once.
Is scheduled to undergo at least 1 ketamine infusion for the treatment of any chronic pain condition.
Have a valid email address and consents to receiving surveys by email.
Able to read, understand, and respond to English-language surveys on an electronic device such as a cell phone, tablet, or computer.
Able to read, understand, and provide written, dated informed consent.

Exclusion criteria